2',3'-cyclic nucleotide 3'-phosphodiesterases inhibit hepatitis B virus replication

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Ma, Hui ^a   Zhao, Xing Liang ^a   Wang, Xue Yan ^a   Xie, Xing Wang ^a   Han, Jin Chao ^a   Guan, Wen Li ^a   Wang, Qin ^a   Zhu, Lin ^a   Pan, Xiao Ben ^a   Wei, Lai ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; CELL LINE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTRACELLULAR SPACE; ISOENZYMES; LIVER; PROTEIN TRANSPORT; VIRUS REPLICATION;

EID: 84894054701     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080769     Document Type: Article

References (36)

1. Kozlov G, Lee J, Elias D, Gravel M, Gutierrez P et al. (2003) Structural evidence that brain cyclic nucleotide phosphodiesterase is a member of the 2H phosphodiesterase superfamily. J Biol Chem 278: 46021-46028. doi:10.1074/jbc.M305176200. PubMed: 12947117. (Pubitemid 37432751)
2. Myllykoski M, Itoh K, Kangas SM, Heape AM, Kang SU et al. (2012) The N-terminal domain of the myelin enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase: direct molecular interaction with the calcium sensor calmodulin. J Neurochem 123: 515-524. doi:10.1111/jnc.12000. PubMed: 22928743.
3. Stingo S, Masullo M, Polverini E, Laezza C, Ruggiero I et al. (2007) The N-terminal domain of 2',3'-cyclic nucleotide 3'-phosphodiesterase harbors a GTP/ATP binding site. Chem Biol Drugs Des 70: 502-510. doi:10.1111/j.1747-0285. 2007.00592.x. PubMed: 17986204. (Pubitemid 350150874)
4. Sakamoto Y, Tanaka N, Ichimiya T, Kurihara T, Nakamura KT (2005) Crystal structure of the catalytic fragment of human brain 2',3'-cyclic-nucleotide 3'-phosphodiesterase. J Mol Biol, 346: l346:789-800. PubMed: 15713463. (Pubitemid 40247718)
5. Lee J, Gravel M, Gao E, O'Neill RC, Braun PE (2001) Identification of essential residues in 2',3'-cyclic nucleotide 3'-phosphodiesterase. Chemical modification and site-directed mutagenesis to investigate the role of cysteine and histidine residues in enzymatic activity. J Biol Chem 276: 14804-14813. doi:10.1074/jbc.M009434200. PubMed: 11278504.
6. Bifulco M, Laezza C, Stingo S, Wolff J (2002) 2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin. Proc Natl Acad Sci U S A 99: 1807-1812. doi:10.1073/pnas.042678799. PubMed: 11842207. (Pubitemid 34168971)
7. Esposito C, Scrima M, Carotenuto A, Tedeschi A, Rovero P et al. (2008) Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2',3'-cyclic nucleotide-3'-phosphodiesterase. Biochemistry 47: 308-319. doi:10.1021/bi701474t. PubMed: 18076147.
8. Calvin K, Li H (2008) RNA-splicing endonuclease structure and function. Cell Mol Life Sci 65: 1176-1185. doi:10.1007/s00018-008-7393-y. PubMed: 18217203.
9. Sprinkle TJ, Agee JF, Tippins RB, Chamberlain CR, Faguet GB et al. (1987) Monoclonal antibody production to human and bovine 2':3'-cyclic nucleotide 3'-phosphodiesterase (CNPase): high-specificity recognition in whole brain acetone powders and conservation of sequence between CNP1 and CNP2. Brain Res 426:349-357. (Pubitemid 17155618)
10. Lee J, O'Neill RC, Park MW, Gravel M, Braun PE (2006) Mitochondrial localization of CNP2 is regulated by phosphorylation of the N-terminal targeting signal by PKC: implications of a mitochondrial function for CNP2 in glial and non-glial cells. Mol Cell Neurosci 31: 446-462. doi: 10.1016/j.mcn.2005.10.017. PubMed: 16343930. (Pubitemid 43358019)
11. Edwards AM, Braun PE (1988) Gene expression of the central and peripheral nervous system myelin membrane 2', 3'-cyclic nucleotide 3'-phosphodiesterase in development. Dev Neurosci 10: 75-80. doi:10.1159/000111958. PubMed: 2841085.
12. Radtke C, Sasaki M, Lankford KL, Gallo V, Kocsis JD (2011) CNPase expression in olfactory ensheathing cells. J Biomed Biotechnol 2011:608496. PubMed: 22174557
13. Gravel M, Robert F, Kottis V, Gallouzi IE, Pelletier J et al. (2009) 2',3'-Cyclic nucleotide 3'-phosphodiesterase: a novel RNA-binding protein that inhibits protein synthesis. J Neurosci Res 87: 1069-1079. doi:10.1002/jnr.21939. PubMed: 19021295.
14. Wilson SJ, Schoggins JW, Zang T, Kutluay SB, Jouvenet N et al. (2012) Inhibition of HIV-1 Particle Assembly by 2',3'-Cyclic-Nucleotide 3'-Phosphodiesterase. Cell Host Microbe 12: 585-597. doi:10.1016/j.chom.2012.08. 012. PubMed: 23084924.
15. Ganem D, Prince AM (2004) Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350: 1118-1129. doi:10.1056/NEJMra031087. PubMed: 15014185. (Pubitemid 38298992)
16. Perfumo S, Amicone L, Colloca S, Giorgio M, Pozzi L et al. (1992) Recognition efficiency of the hepatitis B virus polyadenylation signals is tissue specific in transgenic mice. J Virol 66: 6819-6823. PubMed: 1357192.
17. Seeger C, Mason WS (2000) Hepatitis B virus biology. Microbiol Mol Biol Rev 64: 51-68. doi:10.1128/MMBR.64.1.51-68.2000. PubMed: 10704474. (Pubitemid 30143840)
18. Feng Y, Kong YY, Wang Y, Qi GR (2001) Inhibition of hepatitis B virus by hammerhead ribozyme targeted to the poly(A) signal sequence in cultured cells. Biol Chem 382: 655-660. PubMed: 11405228. (Pubitemid 32472176)
19. Wang Y, Wei L, Jiang D, Cong X, Fei R et al. (2005) In vitro resistance to interferon of hepatitis B virus with precore mutation. World J Gastroenterol;11: 649-655. PubMed: 15655815. (Pubitemid 40220751)
20. Jiang D, Guo H, Xu C, Chang J, Gu B et al. (2007) Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol 82: 1665-1678. PubMed: 18077728. (Pubitemid 351206918)
21. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L et al. (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33: 401-406. doi:10.1038/ng1117. PubMed: 12590264. (Pubitemid 36278858)
22. Lau DT, Fish PM, Sinha M, Owen DM, Lemon SM et al. (2008) Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients. Hepatology 47: 799-809. doi:10.1002/hep.22076. PubMed: 18203148. (Pubitemid 351449671)
23. Pan XB, Wei L, Han JC, Gao Y (2008) Cellular chromosome DNA interferes with fluorescence quantitative real-time PCR detection of HBV DNA in culture medium. J Med Virol 80: 47-52. doi:10.1002/jmv.21042. PubMed: 18041004. (Pubitemid 350220087)
24. Pan XB, Wei L, Chen HS, Liu F, Gao Y (2007) Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patterns. Arch Virol 152: 1159-1173. doi:10.1007/s00705-006-0927-4. PubMed: 17308979. (Pubitemid 46800705)
25. McFerran B, Burgoyne R (1997) 2',3'-Cyclic nucleotide 3'-phosphodiesterase is associated with mitochondria in diverse adrenal cell types. J Cell Sci 110: 2979-2985. PubMed: 9359886. (Pubitemid 28005813)
26. Dreiling CE, Schilling RJ, Reitz RC (1981) 2',3'-cyclic nucleotide 3'-phosphohydrolase in rat liver mitochondrial membranes. Biochim Biophys Acta 640: 114-120. doi:10.1016/0005-2736(81)90537-X. PubMed: 6260166.
27. Isogawa M, Robek MD, Furuichi Y, Chisari FV (2005) Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 79: 7269-7272. doi:10.1128/JVI.79.11.7269-7272.2005. PubMed: 15890966. (Pubitemid 40677357)
28. Chen J, Wu M, Zhang X, Zhang W, Zhang Z et al. (2013) Hepatitis B virus polymerase impairs interferon-α-induced STATs activation through inhibition of importin-α5 and protein kinase C-δ. Hepatology 57: 470-482. doi:10.1002/hep.26064. PubMed: 22996189.
29. Perrillo R (2009) Benefits and risks of interferon therapy for hepatitis B. Hepatology 49: S103-S111. doi:10.1002/hep.22956. PubMed: 19399806.
30. Nguyen DH, Gummuluru S, Hu J (2007) Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G. J Virol 81: 4465-4472. doi:10.1128/JVI.02510-06. PubMed: 17314171. (Pubitemid 46668644)
31. Nguyen DH, Hu J (2008) Reverse transcriptase-and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids. J Virol 82: 6852-6861. doi:10.1128/JVI.00465-08. PubMed: 18480459. (Pubitemid 351977706)
32. Gordien E, Rosmorduc O, Peltekian C, Garreau F, Bréchot C et al. (2001) Inhibition of hepatitis B virus replication by the interferoninducible MxA protein. J Virol 75: 2684-2691. doi:10.1128/JVI.75.6.2684-2691.2001. PubMed: 11222692. (Pubitemid 32185032)
33. Li N, Zhang L, Chen L, Feng W, Xu Y et al. (2012) MxA inhibits hepatitis B virus replication by interaction with hepatitis B core antigen. Hepatology 56: 8003-8011. PubMed: 22271421.
34. Gao B, Duan Z, Xu W, Xiong S (2009) Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology 50: 424-433. doi:10.1016/j.jhep.2008.11. 004. PubMed: 19585648.
35. Mao R, Zhang J, Jiang D, Cai D, Levy JM et al. (2011) Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells. J Virol 85: 1048-1057. doi:10.1128/JVI.01998-10. PubMed: 21084489.
36. Park IH, Baek KW, Cho EY, Ahn BY (2011) PKR-dependent mechanisms of interferon-α for inhibiting hepatitis B virus replication. Mol Cells 32: 167-172. doi:10.1007/s10059-011-1059-6. PubMed: 21710204.